Despite the ongoing doom and gloom amid the stock markets, recruitment within the biotechnology and clinical research industries continues to provide a ray of sunshine
Comparing 2002 to 2001, rolling twelve month results to the end of July reveal a massive 13.6% hike in invoice value, and a 10.4% increase in job orders.
Average placement fee rose by 6.6% (reflecting a commensurate increase in salaries offered to candidates).
Just as encouraging was the news reported on 24 July in the Cambridge Evening News, that œ6 million is being invested in Cambridge biotech companies.
The continuing year-on-year increase in Seltek's revenues, the growth in job opportunities, and the obvious faith that investment companies have in the biotech sector gives us great optimism for the future.
As a measure of the company's faith in the validity of this niche market, it is expanding, and has two opportunities for people to train as recruitment consultants.
If you, or anyone you know can offer a scientific background (preferably lifescience), some commercial experience, and oodles of enthusiasm, then please contact Guy Buncombe at Seltek.
